Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Net Income: 2019-2023

Historic Net Income for ADC Therapeutics (ADCT) over the last 5 years, with Sep 2023 value amounting to -$45.3 million.

  • ADC Therapeutics' Net Income rose 12.93% to -$45.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$153.5 million, marking a year-over-year decrease of 11.71%. This contributed to the annual value of -$153,522 for FY2022, which is 43.76% up from last year.
  • Per ADC Therapeutics' latest filing, its Net Income stood at -$45.3 million for Q3 2023, which was up 6.01% from -$48.2 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Net Income registered a high of -$16,223 during Q4 2022, and its lowest value of -$126.3 million during Q2 2020.
  • In the last 3 years, ADC Therapeutics' Net Income had a median value of -$51.3 million in 2021 and averaged -$44.1 million.
  • In the last 5 years, ADC Therapeutics' Net Income slumped by 480,314.45% in 2020 and then spiked by 79.29% in 2022.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Net Income stood at -$35,055 in 2019, then plummeted by 65,908.76% to -$20.3 million in 2020, then tumbled by 250.44% to -$78,323 in 2021, then skyrocketed by 79.29% to -$16,223 in 2022, then increased by 12.93% to -$45.3 million in 2023.
  • Its last three reported values are -$45.3 million in Q3 2023, -$48.2 million for Q2 2023, and -$60.0 million during Q1 2023.